IMMUNOLOGY × HUMAN GENETICS

Kazuyuki Meguro

Uncovering the principles
of immunity through
human genetics.

From rare variants discovered in the clinic to molecular mechanisms and disease models—
translating human genetics into diagnosis and therapy.

Institute for Advanced Academic Research / Chiba University Hospital
Allergy and Clinical Immunology | M.D., Ph.D.

TLR7-related diseasesMonogenic diseaseAutoimmunityTranslational research

02 / RESEARCH

Research Themes

We begin with genetic clues found in patients,
establish causal mechanisms experimentally, and translate them into therapy.

01TLR7 & AUTOIMMUNITY

TLR7 and Autoimmunity

Why does an immune sensor turn against the self?

Starting from gain-of-function TLR7 variants identified in severe SLE, we investigate how altered response thresholds and RNA-ligand recognition drive autoimmunity in human cells and disease models.

  • SLE
  • TLR7
  • RNA sensing
  • ligand specificity
02MONOGENIC IMMUNE DISEASE

Monogenic Immune Diseases

Reading the principles of human immunity from a single variant.

We analyze patient genomes in inborn errors of immunity and immune dysregulation, then test candidate variants at the molecular and cellular levels. Our aim extends beyond diagnosis to the principles of host defense and immune homeostasis.

  • IEI
  • clinical genomics
  • variant interpretation
  • SBNO2 / BTK
03TRANSLATIONAL IMMUNOLOGY

From Clinic to Mechanism and Therapy

Turning rare cases into the next diagnosis and treatment.

We move iteratively among clinical phenotypes, whole-exome sequencing, functional assays, disease models, and omics to establish causal chains in disease, while accounting for differences between humans and model organisms.

  • WES
  • functional validation
  • disease model
  • single-cell
01CLINICPhenotype
02GENEVariant discovery
03MECHANISMFunctional testing
04MODELDisease modeling
05TRANSLATIONDiagnosis & therapy

03 / FOR THE PUBLIC

From one patient
to the next therapy.

The immune system protects us from bacteria and viruses. But when it responds too strongly—or targets the wrong thing—it can damage our own bodies and cause immune disease.

We use small genetic differences found in patients as clues, test how disease develops, and work toward new diagnostic and therapeutic approaches. Rare-disease research takes time and sustained support. Donations help fund genetic analysis, experiments in cells and disease models, and the work needed to bring therapeutic candidates closer to patients.

Analyze genesEstablish causalityAdvance therapy

When donating through the Chiba University Future Medical Fund, please enter both “目黒免疫遺伝子研究” and “アレルギー臨床免疫学 目黒和行” as the designated use of funds.

04 / SELECTED WORKS

Selected Works

View all publications
  1. 202601

    Atypical X-linked agammaglobulinemia diagnosed in adulthood with arthritis caused by a hypomorphic BTK splice-site variant

    Takayama A, Meguro K, et al. · Frontiers in Immunology 17:1849090

    Genetic and functional analysis of XLA diagnosed in adulthood

  2. 202602

    A Case of a Novel Perforin Gene Variant in Severe Familial Hemophagocytic Lymphohistiocytosis Type 2 (FHL2)

    Yamauchi H, Hino M, Meguro K, Yamashita Y, et al. · Case Reports in Hematology 2026:1949986

    Genetic and functional analysis of FHL2 carrying a novel PRF1 A21V variant

  3. 2025PREPRINT

    TLR7 Variants Enhance Responsiveness and Broaden RNA Specificity To Drive Human Lupus

    Takayama A, Meguro K, et al. · medRxiv

    Connecting altered TLR7 ligand specificity to human lupus

  4. 202404

    Germline mutations in a G protein identify signaling cross-talk in T cells

    Ham H, Jing H, Lamborn IT, et al. · Science 385:eadd8947

    Human genetics reveals signaling cross-talk in T cells

  5. 2020COVID HGE

    Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Zhang Q, Bastard P, Liu Z, et al.; COVID Human Genetic Effort · Science 370:eabd4570

    TLR3- and IRF7-dependent type I interferon defects underlying life-threatening COVID-19

  6. 201506

    Role of Bcl-3 in the Development of Follicular Helper T Cells and in the Pathogenesis of Rheumatoid Arthritis

    Meguro K, et al. · Arthritis & Rheumatology 67:2651–2660

    Bcl-3 control of Tfh-cell development and rheumatoid arthritis pathogenesis

05 / TRACK RECORD

Awards, Funding & Talks

A / AWARDS

Awards

  1. 2024Chiba University Future Medical Fund Research GrantDeveloping new therapies for autoimmune disease from whole-exome sequencing of patients with immune disorders
  2. 2023Young Investigator’s Poster Award (Clinical)The 2nd International Symposium of Clinical Immunology
  3. 2022NIH Fellows Award for Research Excellence (FARE) 2023National Institutes of Health
  4. 2018JSPS Overseas Research FellowshipNational Institutes of Health, USA

F / FUNDING

Funding

  1. 2025–27JSPS KAKENHI Grant-in-Aid for Scientific Research (B) | Co-investigatorThe role of nucleic-acid metabolism in autoimmune and autoinflammatory diseases
  2. 2026–28JSPS KAKENHI Grant-in-Aid for Scientific Research (C)Genetic evidence linking altered TLR7 ligand specificity to SLE
  3. 2023–24JSPS KAKENHI Transformative Research Areas (A)Self-directed immunity: immune-sensor mislocalization and human autoimmune disease
  4. 2023–25JSPS KAKENHI Grant-in-Aid for Scientific Research (C)A novel TLR7 variant in severe juvenile SLE and its disease mechanism
  5. 2024–25Chiba University Future Medical Fund Research GrantDeveloping new therapies for autoimmune disease from whole-exome sequencing of immune-disease patients
  6. 2023–28Takeda Science Foundation Medical Research Grant and Continuation Grant (Clinical)A therapeutic platform inspired by a gain-of-function TLR7 variant from severe SLE
  7. 2022–24JSPS KAKENHI Grant-in-Aid for Early-Career Scientists — Start-upMolecular regulation of SBNO2, a newly identified immune-dysregulation gene
  8. 2016–17JSPS KAKENHI Grant-in-Aid for Young Scientists (B)Differentiation of iTR35 cells and their role in rheumatoid arthritis

P / PRESENTATIONS

Presentations

  1. 2024Unwinding the molecular pathogenesis of a novel inherited immunodysregulatory disorder caused by loss-of-function mutations in DExD/H box helicase SBNO2The 5th Asia-Pacific Society for Immunodeficiency (APSID) Congress 2024
  2. 2023SBNO2 deficiency, a novel inherited immunodysregulatory syndrome, reveals new molecular mechanisms in host defensesThe 9th Global Network Forum on Infection and Immunity: Neo Mycology — Invited
  3. 2022Unwinding the molecular pathogenesis of a novel inherited immunodysregulatory disorder caused by loss-of-function mutations in DExD/H box helicase SBNO2The 51st Annual Meeting of the Japanese Society for Immunology — Symposium
  4. 2015Roles of B Cell Leukemia/Lymphoma 3 in the Development of T Follicular Helper Cells and the Pathogenesis of Rheumatoid ArthritisEULAR Congress 2015 — Rome, Italy